Boston Medical Center

bmc.org

Total trials

317

Active

39

Phase 3

17

Total enrollment

545,996

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 12 of 12 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Probiotic1
prabotulinumtoxinA-xvfs1
Gardasil 9 2 dose regimen1
Gardasil 9 3 dose regimen1
Gardasil 9 rescue dose1
Gabapentin2
Gardasil91
Ensure Surgery Immunonutrition Shake1
Ensure Enlive Advanced Nutrition Shake1
clonality analysis1
polymerase chain reaction1
protein analysis1

Next readouts

  • 2026-04-15
  • 2026-06
  • 2026-08
  • 2026-08
  • 2027-06
  • 2028-07
  • 2040-12

Top conditions

  • HIV Infection10
  • Depression9
  • HIV Infections9
  • Obesity8
  • Multiple Myeloma7
  • Anxiety6
  • Pain6
  • Hypertension6

Frequently asked questions about Boston Medical Center

How many clinical trials does Boston Medical Center have on ClinicalTrials.gov?
Boston Medical Center is listed as the lead sponsor on 317 clinical trials in ClinicalTrials.gov, 39 of which are currently active (recruiting, enrolling, or ongoing).
How many of Boston Medical Center's trials are in Phase 3?
17 of Boston Medical Center's trials are in Phase 3, spread across 12 active drug programs.
What therapeutic areas does Boston Medical Center focus on?
Boston Medical Center's most-studied conditions on ClinicalTrials.gov are HIV Infection, Depression, HIV Infections, Obesity, Multiple Myeloma.
When are Boston Medical Center's next clinical trial readouts?
Boston Medical Center has 7 upcoming primary-completion readouts tracked here; the soonest is “An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen”, expected around 2026-04-15.